Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 184

Similar articles for PubMed (Select 19013005)

1.

Identification of primary MAFB target genes in multiple myeloma.

van Stralen E, van de Wetering M, Agnelli L, Neri A, Clevers HC, Bast BJ.

Exp Hematol. 2009 Jan;37(1):78-86. doi: 10.1016/j.exphem.2008.08.006. Epub 2008 Nov 13.

PMID:
19013005
2.

Frequent dysregulation of the c-maf proto-oncogene at 16q23 by translocation to an Ig locus in multiple myeloma.

Chesi M, Bergsagel PL, Shonukan OO, Martelli ML, Brents LA, Chen T, Schröck E, Ried T, Kuehl WM.

Blood. 1998 Jun 15;91(12):4457-63.

3.

Ectopic expression of MAFB gene in human myeloma cells carrying (14;20)(q32;q11) chromosomal translocations.

Hanamura I, Iida S, Akano Y, Hayami Y, Kato M, Miura K, Harada S, Banno S, Wakita A, Kiyoi H, Naoe T, Shimizu S, Sonta SI, Nitta M, Taniwaki M, Ueda R.

Jpn J Cancer Res. 2001 Jun;92(6):638-44.

PMID:
11429052
4.

The recurrent translocation t(14;20)(q32;q12) in multiple myeloma results in aberrant expression of MAFB: a molecular and genetic analysis of the chromosomal breakpoint.

Boersma-Vreugdenhil GR, Kuipers J, Van Stralen E, Peeters T, Michaux L, Hagemeijer A, Pearson PL, Clevers HC, Bast BJ.

Br J Haematol. 2004 Aug;126(3):355-63.

PMID:
15257707
5.

Molecular characterization of human multiple myeloma cell lines by integrative genomics: insights into the biology of the disease.

Lombardi L, Poretti G, Mattioli M, Fabris S, Agnelli L, Bicciato S, Kwee I, Rinaldi A, Ronchetti D, Verdelli D, Lambertenghi-Deliliers G, Bertoni F, Neri A.

Genes Chromosomes Cancer. 2007 Mar;46(3):226-38.

PMID:
17171682
6.

Characterization of oncogene dysregulation in multiple myeloma by combined FISH and DNA microarray analyses.

Fabris S, Agnelli L, Mattioli M, Baldini L, Ronchetti D, Morabito F, Verdelli D, Nobili L, Intini D, Callea V, Stelitano C, Lombardi L, Neri A.

Genes Chromosomes Cancer. 2005 Feb;42(2):117-27.

PMID:
15543617
7.

ARK5 is transcriptionally regulated by the Large-MAF family and mediates IGF-1-induced cell invasion in multiple myeloma: ARK5 as a new molecular determinant of malignant multiple myeloma.

Suzuki A, Iida S, Kato-Uranishi M, Tajima E, Zhan F, Hanamura I, Huang Y, Ogura T, Takahashi S, Ueda R, Barlogie B, Shaughnessy J Jr, Esumi H.

Oncogene. 2005 Oct 20;24(46):6936-44.

PMID:
16044163
8.

Neither MafA/L-Maf nor MafB is essential for lens development in mice.

Takeuchi T, Kudo T, Ogata K, Hamada M, Nakamura M, Kito K, Abe Y, Ueda N, Yamamoto M, Engel JD, Takahashi S.

Genes Cells. 2009 Aug;14(8):941-7. doi: 10.1111/j.1365-2443.2009.01321.x. Epub 2009 Jul 17.

PMID:
19624757
9.
10.

Identification of overexpressed genes in frequently gained/amplified chromosome regions in multiple myeloma.

Largo C, Alvarez S, Saez B, Blesa D, Martin-Subero JI, González-García I, Brieva JA, Dopazo J, Siebert R, Calasanz MJ, Cigudosa JC.

Haematologica. 2006 Feb;91(2):184-91.

11.

Expression of a novel gene, MafB, in Dupuytren's disease.

Lee LC, Zhang AY, Chong AK, Pham H, Longaker MT, Chang J.

J Hand Surg Am. 2006 Feb;31(2):211-8.

PMID:
16473681
12.

TFE3 transcription factor regulates the expression of MAFB during macrophage differentiation.

Zanocco-Marani T, Vignudelli T, Parenti S, Gemelli C, Condorelli F, Martello A, Selmi T, Grande A, Ferrari S.

Exp Cell Res. 2009 Jul 1;315(11):1798-808. doi: 10.1016/j.yexcr.2009.03.018. Epub 2009 Mar 28.

PMID:
19332055
13.

Gene expression profiling of plasma cell dyscrasias reveals molecular patterns associated with distinct IGH translocations in multiple myeloma.

Mattioli M, Agnelli L, Fabris S, Baldini L, Morabito F, Bicciato S, Verdelli D, Intini D, Nobili L, Cro L, Pruneri G, Callea V, Stelitano C, Maiolo AT, Lombardi L, Neri A.

Oncogene. 2005 Apr 7;24(15):2461-73.

PMID:
15735737
14.

A novel molecular mechanism involved in multiple myeloma development revealed by targeting MafB to haematopoietic progenitors.

Vicente-Dueñas C, Romero-Camarero I, González-Herrero I, Alonso-Escudero E, Abollo-Jiménez F, Jiang X, Gutierrez NC, Orfao A, Marín N, Villar LM, Criado MC, Pintado B, Flores T, Alonso-López D, De Las Rivas J, Jiménez R, Criado FJ, Cenador MB, Lossos IS, Cobaleda C, Sánchez-García I.

EMBO J. 2012 Sep 12;31(18):3704-17. doi: 10.1038/emboj.2012.227. Epub 2012 Aug 17.

15.

c-Maf and MafB transcription factors are differentially expressed in Huxley's and Henle's layers of the inner root sheath of the hair follicle and regulate cuticle formation.

Miyai M, Tanaka YG, Kamitani A, Hamada M, Takahashi S, Kataoka K.

J Dermatol Sci. 2010 Mar;57(3):178-82. doi: 10.1016/j.jdermsci.2009.12.011. Epub 2010 Jan 8.

PMID:
20060689
16.

C-MAF oncogene dysregulation in multiple myeloma: frequency and biological relevance.

Rasmussen T, Knudsen LM, Dahl IM, Johnsen HE.

Leuk Lymphoma. 2003 Oct;44(10):1761-6.

PMID:
14692531
17.

Identification of ID-1 as a potential target gene of MMSET in multiple myeloma.

Hudlebusch HR, Theilgaard-Mönch K, Lodahl M, Johnsen HE, Rasmussen T.

Br J Haematol. 2005 Sep;130(5):700-8.

PMID:
16115125
18.

Overexpression of c-maf is a frequent oncogenic event in multiple myeloma that promotes proliferation and pathological interactions with bone marrow stroma.

Hurt EM, Wiestner A, Rosenwald A, Shaffer AL, Campo E, Grogan T, Bergsagel PL, Kuehl WM, Staudt LM.

Cancer Cell. 2004 Feb;5(2):191-9.

19.

Cyclin D3 at 6p21 is dysregulated by recurrent chromosomal translocations to immunoglobulin loci in multiple myeloma.

Shaughnessy J Jr, Gabrea A, Qi Y, Brents L, Zhan F, Tian E, Sawyer J, Barlogie B, Bergsagel PL, Kuehl M.

Blood. 2001 Jul 1;98(1):217-23.

20.

Early genetic events provide the basis for a clinical classification of multiple myeloma.

Kuehl WM, Bergsagel PL.

Hematology Am Soc Hematol Educ Program. 2005:346-52.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk